文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

整合素β3通过调控脓毒症巨噬细胞CD14表达调节TLR4介导的炎症

Integrin β3 Modulates TLR4-Mediated Inflammation by Regulation of CD14 Expression in Macrophages in Septic Condition.
PubMed 文献 · Shock · 2020-01-01
一句话结论脓毒症中整合素β3正向调控TLR4介导的炎症反应,靶向整合素β3/TLR4-CD14信号通路可能是多微生物脓毒症的潜在治疗策略。

该研究利用盲肠结扎穿刺(CLP)诱导的脓毒症模型和脂多糖(LPS)处理的巨噬细胞模型,探讨整合素β3与TLR4信号的机制。在致死性CLP模型中,整合素β3小鼠的生存率高于野生型小鼠,血清丙氨酸氨基转移酶、天冬氨酸转氨酶、肌酐、血尿素氮和乳酸脱氢酶水平及组织中CD14蛋白表达显著降低。在野生型巨噬细胞中,用P11或特异性抗体抑制整合素β3可抑制LPS刺激早期TNF-α和IL-6释放,但晚期无此效应,且CD14表达无变化;而整合素β3巨噬细胞中LPS诱导的TNF-α、IL-6释放和CD14表达显著降低。抑制TLR4通路(TAK-242或TLR4突变巨噬细胞)可消除LPS诱导的CD14表达。结论认为整合素β3通过CD14表达正向调控脓毒症巨噬细胞中TLR4介导的炎症反应。

要点

  • 致死性CLP脓毒症模型中,整合素β3小鼠生存率高于野生型小鼠。
  • 整合素β3小鼠血清丙氨酸氨基转移酶、天冬氨酸转氨酶、肌酐、血尿素氮和乳酸脱氢酶水平及组织CD14蛋白表达显著降低。
  • 野生型巨噬细胞中,P11或特异性抗体抑制整合素β3仅在LPS刺激早期抑制TNF-α和IL-6释放,晚期无此效应,CD14表达无变化。
  • 整合素β3巨噬细胞中LPS诱导的TNF-α、IL-6释放和CD14表达显著降低;TAK-242或TLR4突变可消除LPS诱导的CD14表达。
  • 作者认为特异性靶向整合素β3/TLR4-CD14信号通路可能是多微生物脓毒症的潜在治疗策略。

适用人群与场景

  • 盲肠结扎穿刺(CLP)诱导的脓毒症小鼠模型及LPS处理的巨噬细胞模型。

研究设计与关键结果

  • 研究类型为动物实验和细胞实验,采用CLP诱导的脓毒症模型和LPS处理的巨噬细胞模型。
  • 致死性CLP模型中,整合素β3小鼠生存率高于野生型小鼠。
  • 整合素β3小鼠血清丙氨酸氨基转移酶、天冬氨酸转氨酶、肌酐、血尿素氮和乳酸脱氢酶水平及组织CD14蛋白表达显著低于野生型小鼠;脓毒症TLR4小鼠中观察到类似的CD14下调效应。
  • 野生型巨噬细胞中,P11或特异性抗体抑制整合素β3在LPS刺激早期抑制TNF-α和IL-6释放,晚期无此效应,CD14表达无变化;整合素β3巨噬细胞中LPS诱导的TNF-α、IL-6释放和CD14表达显著降低。
  • TAK-242抑制TLR4通路或TLR4突变巨噬细胞中,LPS诱导的CD14表达被消除;玻璃粘连蛋白激活整合素β3通路对CD14表达无影响。
  • 重组CD14蛋白刺激可逆转整合素β3缺陷并导致较低的TNF-α和IL-6释放;LPS刺激后TLR4与整合素β3的分子相互作用显著增加。

证据类型、等级与局限

  • 证据类型:动物实验和细胞实验(基础研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为特异性靶向整合素β3/TLR4-CD14信号通路可能是多微生物脓毒症的潜在治疗策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Sepsis is a major challenge in clinical practice and responsible for high mortality. Recent studies indicated that integrins participated in toll-like-receptor (TLR)-mediated innate immunity. In the present study, we investigated the mechanism of integrin β3 and TLR4 signaling using a cecal ligation and puncture (CLP)-induced sepsis and lipopolysaccharide (LPS)-treated macrophage cell model. In a lethal CLP model, the survival rate of integrin β3 mice was higher than that of wild-type mice. The levels of alanine aminotransferase, aspartate transaminase, creatinine, blood urea nitrogen , and lactate dehydrogenase in the serum and cluster of differentiation 14 (CD14) protein expression in the tissues were significantly decreased in integrin β3 mice. A similar effect with regard to CD14 down-regulation was observed in septic TLR4 mice. In wild-type macrophages, the inhibition of integrin β3 by P11 or with a specific antibody, inhibited TNF-α, and IL-6 release at the early time period of LPS stimulation. However, during the late periods of LPS stimulation this effect was not noted. CD14 expression levels had no change in such treatment. In contract, LPS-induced TNF-α and IL-6 release and LPS-induced CD14 expression were significantly decreased in integrin β3macrophages. The inhibition of the TLR4 pathway by TAK-242, or in TLR4 mutant macrophages abolished LPS-induced CD14 expression. Integrin β3 pathway activation by vitronectin exhibited no effect in CD14 expression. Furthermore, recombinant CD14 protein stimulation reversed integrin β3 deficiency and caused lower TNF-α and IL-6 release. Moreover, the molecular interaction of TLR4 and integrin β3 was significantly increased following LPS stimulation. In conclusion, integrin β3 positively regulated TLR4-mediated inflammatory responses via CD14 expression in macrophages in septic condition. Specifically targeting integrin β3/TLR4-CD14 signaling pathway may be a potential treatment strategy for polymicrobial sepsis.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Chen Z, Wang S, Chen Y, et al. Integrin β3 Modulates TLR4-Mediated Inflammation by Regulation of CD14 Expression in Macrophages in Septic Condition. Shock. 2020. PMID: 31135705. doi:10.1097/SHK.0000000000001383

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。